Objective:

To evaluate the effectiveness of inferior turbinate reduction compared to continued medical therapy in pediatric patients with refractory allergic rhinitis.

Approach:

Key Findings:

• Surgery resulted in greater mean reductions in symptom scores at 1 month compared to medical therapy.
• At 1 month, complete disease regression was observed in 88% of surgical patients versus 29% of those receiving medical therapy.
• At 3 months, surgical patients continued to show greater reductions in symptom scores and reduced dependence on medications.

Interpretation:

Inferior turbinate reduction significantly improves sinonasal symptoms, nasal obstruction, and sleep-related quality of life in children with refractory allergic rhinitis compared to continued medical therapy.

Limitations:

• Small sample size and limited follow-up (only 20 of 34 patients at 3 months).
• Non-randomized group allocation may introduce selection bias.
• Outcomes based on patient-reported questionnaires without objective measures.

Conclusion:

Inferior turbinate reduction is a promising surgical option for pediatric patients with refractory allergic rhinitis, showing significant improvements in quality of life and symptom relief.

Sources:

• American Journal of Otolaryngology
Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.